These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28948755)

  • 41. Interferon-Free Therapy for Hepatitis C in Liver Transplant Recipients.
    Ueda Y; Uemoto S
    Transplantation; 2016 Jan; 100(1):54-60. PubMed ID: 26335914
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of HCV transplant patients with triple therapy.
    Coilly A; Roche B; Duclos-Vallée JC; Samuel D
    Liver Int; 2014 Feb; 34 Suppl 1():46-52. PubMed ID: 24373078
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost Effectiveness of Pre- vs Post-Liver Transplant Hepatitis C Treatment With Direct-Acting Antivirals.
    Samur S; Kues B; Ayer T; Roberts MS; Kanwal F; Hur C; Donnell DMS; Chung RT; Chhatwal J
    Clin Gastroenterol Hepatol; 2018 Jan; 16(1):115-122.e10. PubMed ID: 28634131
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pegylated interferon alpha-2a and ribavirin combination therapy in HCV liver transplant recipients. Experience of 7 cases.
    Iacob S; Gheorghe L; Hrehoret D; Becheanu G; Herlea V; Popescu I
    J Gastrointestin Liver Dis; 2008 Jun; 17(2):165-72. PubMed ID: 18568137
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liver transplantation for hepatitis C patients in the era of direct-acting antiviral treatment: A retrospective cohort study.
    Khan AS; Adams N; Vachharajani N; Dageforde L; Wellen J; Shenoy S; Crippin JS; Doyle MB; Chapman WC
    Int J Surg; 2020 Mar; 75():84-90. PubMed ID: 32014598
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A review of the treatment of chronic hepatitis C virus infection in cirrhosis.
    Vezali E; Aghemo A; Colombo M
    Clin Ther; 2010 Dec; 32(13):2117-38. PubMed ID: 21316532
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of liver transplantation waiting list for decompensated cirrhosis in a Spanish tertiary hospital: differences between hepatitis C virus recipients and other etiologies.
    Ibáñez Samaniego L; Pérez Valderas M; Fernández Yunquera A; Rincón Rodríguez D; López Baena JA; Matilla Peña A; Catalina Rodríguez MV; Clemente Ricote G; Bañares Cañizares R; Salcedo Plaza M
    Transplant Proc; 2014 Nov; 46(9):3084-6. PubMed ID: 25420829
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In the Era of Direct-Acting Antivirals, Liver Transplant Delisting Due to Clinical Improvement for Hepatitis C Remains Infrequent.
    Bittermann T; Reddy KR
    Clin Gastroenterol Hepatol; 2021 Nov; 19(11):2389-2397.e2. PubMed ID: 32971230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment strategies for patients with decompensated liver cirrhosis due to hepatitis C virus infection eligible for liver transplantation: real-life data from five German transplant centers.
    Sandmann L; Dörge P; Wranke A; Vermehren J; Welzel TM; Berg CP; Grottenthaler JM; Weiss KH; Langel J; Sterneck M; von Wulffen M; Manns MP; Wedemeyer H; Hardtke S; von Hahn T
    Eur J Gastroenterol Hepatol; 2019 Aug; 31(8):1049-1056. PubMed ID: 30807443
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis C virus treatment pre- and post-liver transplantation.
    Roche B; Samuel D
    Liver Int; 2012 Feb; 32 Suppl 1():120-8. PubMed ID: 22212582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus-infected patients treated with direct-acting antivirals.
    Zanetto A; Shalaby S; Vitale A; Mescoli C; Ferrarese A; Gambato M; Franceschet E; Germani G; Senzolo M; Romano A; Angeli P; Rugge M; Farinati F; Forton DM; Cillo U; Burra P; Russo FP
    Liver Transpl; 2017 Sep; 23(9):1103-1112. PubMed ID: 28544587
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interferon-free antiviral therapy for chronic hepatitis C among patients in the liver transplant setting.
    van Tilborg M; Maan R; van der Meer AJ; de Knegt RJ
    Best Pract Res Clin Gastroenterol; 2017 Apr; 31(2):219-225. PubMed ID: 28624110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of hepatitis C virus (HCV) antiviral treatment on the need for liver transplantation (LT).
    Sáez-González E; Vinaixa C; San Juan F; Hontangas V; Benlloch S; Aguilera V; Rubín A; García M; Prieto M; López-Andujar R; Berenguer M
    Liver Int; 2018 Jun; 38(6):1022-1027. PubMed ID: 29105320
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Indication for Liver Transplantation After Direct-Acting Agents in the Treatment of Patients With Hepatitis C.
    Arias ABV; Villegas Herrera MT; Arco Sánchez A; Adel ME; Triguero Cabrera J; Plata Illescas C; Montes Osuna MC; Santoyo Villalba J; Villar Del Moral JM
    Transplant Proc; 2022; 54(1):32-34. PubMed ID: 34911619
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients.
    Belli LS; Duvoux C; Berenguer M; Berg T; Coilly A; Colle I; Fagiuoli S; Khoo S; Pageaux GP; Puoti M; Samuel D; Strazzabosco M
    J Hepatol; 2017 Sep; 67(3):585-602. PubMed ID: 28323126
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis viruses and liver transplantation: evolving trends in antiviral management.
    Verna EC
    Clin Liver Dis; 2014 Aug; 18(3):575-601. PubMed ID: 25017077
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in practice and perception of hepatitis C and liver transplantation: Results of a national survey.
    Shaffer AA; Thomas AG; Bowring MG; Van Pilsum Rasmussen SE; Cash A; Kucirka LM; Alqahtani SA; Gurakar A; Sulkowski MS; Cameron AM; Segev DL; Durand CM
    Transpl Infect Dis; 2018 Dec; 20(6):e12982. PubMed ID: 30144258
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treating hepatitis C infection in liver transplant recipients.
    Terrault NA; Berenguer M
    Liver Transpl; 2006 Aug; 12(8):1192-204. PubMed ID: 16868944
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current management and perspectives for HCV recurrence after liver transplantation.
    Coilly A; Roche B; Samuel D
    Liver Int; 2013 Feb; 33 Suppl 1():56-62. PubMed ID: 23286847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Direct antiviral therapy for hepatitis C cirrhotic patients in liver transplantation settings: a systematic review.
    Li J; Wu V; Pan CQ
    Hepatol Int; 2022 Oct; 16(5):1020-1031. PubMed ID: 36085539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.